Unless you’ve been hiding under a rock, you are most certainly aware of the seismic impact on the weight loss world brought on by medications like Wegovy and Zepbound (originally approved as Ozempic and Mounjaro for managing A1C among people with diabetes). Research and client workshops are uncovering ripple effects across so many other industries that impact our clients in grocery, retail, food and beverage, apparel, fitness, and areas of healthcare that may not have anticipated these shifts.